IOLCPNSEIOL CHEM AND PHARMA LTD· PharmaceuticalsMediumPositive
Announced Fri, 25 Sept, 2026 · 13:31 IST

EDQM grants CEP for Fenofibrate Process II to IOL Chemicals

Regulatory Product ApprovalBusiness Updates View source PDFExplain this filing

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹202.00
prior close
₹204.74
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.4-0.4+0.3-2.2-0.0+2.3+4.2+2.0+8.5————
Up moveDown movePending
AI summary

IOL Chemicals received a Certificate of Suitability (CEP) from EDQM on 24 Sep 2026 for its API Fenofibrate Process II. This adds to the existing CEP already held by the company for Fenofibrate. The approval lets IOL supply this specific process version to European and other regulated markets, strengthening its regulatory portfolio for the molecule.

Likely market impact

Positive: enables Fenofibrate Process II supply in European regulated markets and supports the company's regulated markets API business.